A blood test using an EPCA enzyme-linked immunosorbent assay has displayed 92% sensitivity and 94% specificity for prostate cancer, suggesting a possibly immensely useful biomarker [ 24].
Because screening mammography for breast cancer is less effective for premenopausal women, we investigated the feasibility of a diagnostic blood test using serum proteins.
The community health workers carried out a blood sugar test using a blood glucose monitoring device at the patients' residence after an overnight fast by the patients.
Take the Diabetes Risk Test and get a blood test used to diagnose diabetes from your doctor if you meet the risk criteria.
We examined whether the oral fluid THC test can be used as a valid alternative to the blood THC test using a sensitivity and specificity analysis and a logistic regression, and estimate the quantitative relationship between oral fluid THC concentration and blood THC concentration using a correlation analysis and a linear regression on the log-transformed THC concentrations.
Community-based screening (n = 19,377) included a short survey, anthropometric measurements, and random capillary blood glucose test using a glucose meter (Lifescan; Johnson & Johnson, Milpitas, CA).
The nurse carried out a finger prick random capillary blood glucose test using a glucose analyser based on the glucose dehydrogenase reaction (HemoCue B-glucose analyser; HemoCue, Angelholm, Sweden).
Respondents with an affirmative response to the question "Have you ever done a blood stool test, using a home test kit?" and/or an affirmative response to the question "Have you ever had a sigmoidoscopy or colonoscopy?" (in 2001 and 2003, this question also included proctoscopy) were classified as ever received CRC screening.
Breast Cancer Action is now among the plaintiffs in a case being considered by the Supreme Court that challenges the right of Myriad Genetics Inc. to patent genes to maintain a monopoly on a blood test used to look for mutations that greatly increase the risk of cancer.
The move came roughly nine months after The Wall Street Journal exposed major problems with the company's technology, which claimed to be able to run more than 240 blood tests using just a drop of blood. .
